These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30883881)

  • 1. Putative structural rearrangements associated with the interaction of macrocyclic inhibitors with norovirus 3CL protease.
    Galasiti Kankanamalage AC; Weerawarna PM; Rathnayake AD; Kim Y; Mehzabeen N; Battaile KP; Lovell S; Chang KO; Groutas WC
    Proteins; 2019 Jul; 87(7):579-587. PubMed ID: 30883881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxadiazole-Based Cell Permeable Macrocyclic Transition State Inhibitors of Norovirus 3CL Protease.
    Damalanka VC; Kim Y; Alliston KR; Weerawarna PM; Galasiti Kankanamalage AC; Lushington GH; Mehzabeen N; Battaile KP; Lovell S; Chang KO; Groutas WC
    J Med Chem; 2016 Mar; 59(5):1899-913. PubMed ID: 26823007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and evaluation of a novel series of macrocyclic inhibitors of norovirus 3CL protease.
    Damalanka VC; Kim Y; Galasiti Kankanamalage AC; Lushington GH; Mehzabeen N; Battaile KP; Lovell S; Chang KO; Groutas WC
    Eur J Med Chem; 2017 Feb; 127():41-61. PubMed ID: 28038326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and inhibitor studies of norovirus 3C-like proteases.
    Takahashi D; Kim Y; Lovell S; Prakash O; Groutas WC; Chang KO
    Virus Res; 2013 Dec; 178(2):437-44. PubMed ID: 24055466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design and synthesis of triazole-based macrocyclic inhibitors of norovirus protease: Structural, biochemical, spectroscopic, and antiviral studies.
    Weerawarna PM; Kim Y; Galasiti Kankanamalage AC; Damalanka VC; Lushington GH; Alliston KR; Mehzabeen N; Battaile KP; Lovell S; Chang KO; Groutas WC
    Eur J Med Chem; 2016 Aug; 119():300-18. PubMed ID: 27235842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based exploration and exploitation of the S
    Galasiti Kankanamalage AC; Kim Y; Rathnayake AD; Damalanka VC; Weerawarna PM; Doyle ST; Alsoudi AF; Dissanayake DMP; Lushington GH; Mehzabeen N; Battaile KP; Lovell S; Chang KO; Groutas WC
    Eur J Med Chem; 2017 Jan; 126():502-516. PubMed ID: 27914364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses.
    Kim Y; Lovell S; Tiew KC; Mandadapu SR; Alliston KR; Battaile KP; Groutas WC; Chang KO
    J Virol; 2012 Nov; 86(21):11754-62. PubMed ID: 22915796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in the Discovery of Norovirus Therapeutics.
    Kim Y; Galasiti Kankanamalage AC; Chang KO; Groutas WC
    J Med Chem; 2015 Dec; 58(24):9438-50. PubMed ID: 26258852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A structural study of norovirus 3C protease specificity: binding of a designed active site-directed peptide inhibitor.
    Hussey RJ; Coates L; Gill RS; Erskine PT; Coker SF; Mitchell E; Cooper JB; Wood S; Broadbridge R; Clarke IN; Lambden PR; Shoolingin-Jordan PM
    Biochemistry; 2011 Jan; 50(2):240-9. PubMed ID: 21128685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral Drug Discovery: Norovirus Proteases and Development of Inhibitors.
    Chang KO; Kim Y; Lovell S; Rathnayake AD; Groutas WC
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30823509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure(s), function(s), and inhibition of the RNA-dependent RNA polymerase of noroviruses.
    Deval J; Jin Z; Chuang YC; Kao CC
    Virus Res; 2017 Apr; 234():21-33. PubMed ID: 28041960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current tools for norovirus drug discovery.
    Weerasekara S; Prior AM; Hua DH
    Expert Opin Drug Discov; 2016 Jun; 11(6):529-41. PubMed ID: 27108716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrocyclic inhibitors of 3C and 3C-like proteases of picornavirus, norovirus, and coronavirus.
    Mandadapu SR; Weerawarna PM; Prior AM; Uy RA; Aravapalli S; Alliston KR; Lushington GH; Kim Y; Hua DH; Chang KO; Groutas WC
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3709-12. PubMed ID: 23727045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norovirus Protease Structure and Antivirals Development.
    Zhao B; Hu L; Song Y; Patil K; Ramani S; Atmar RL; Estes MK; Prasad BVV
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norovirus gastroenteritis, increased understanding and future antiviral options.
    Tan M; Jiang X
    Curr Opin Investig Drugs; 2008 Feb; 9(2):146-51. PubMed ID: 18246517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-norovirus therapeutics: a patent review (2010-2015).
    Galasiti Kankanamalage AC; Weerawarna PM; Kim Y; Chang KO; Groutas WC
    Expert Opin Ther Pat; 2016; 26(3):297-308. PubMed ID: 26881878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances Toward a Norovirus Antiviral: From Classical Inhibitors to Lethal Mutagenesis.
    Thorne L; Arias A; Goodfellow I
    J Infect Dis; 2016 Feb; 213 Suppl 1(Suppl 1):S27-31. PubMed ID: 26744429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-guided design, synthesis and evaluation of oxazolidinone-based inhibitors of norovirus 3CL protease.
    Damalanka VC; Kim Y; Galasiti Kankanamalage AC; Rathnayake AD; Mehzabeen N; Battaile KP; Lovell S; Nguyen HN; Lushington GH; Chang KO; Groutas WC
    Eur J Med Chem; 2018 Jan; 143():881-890. PubMed ID: 29227928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GII.4 Norovirus Protease Shows pH-Sensitive Proteolysis with a Unique Arg-His Pairing in the Catalytic Site.
    Viskovska MA; Zhao B; Shanker S; Choi JM; Deng L; Song Y; Palzkill T; Hu L; Estes MK; Venkataram Prasad BV
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-guided design and optimization of dipeptidyl inhibitors of norovirus 3CL protease. Structure-activity relationships and biochemical, X-ray crystallographic, cell-based, and in vivo studies.
    Galasiti Kankanamalage AC; Kim Y; Weerawarna PM; Uy RA; Damalanka VC; Mandadapu SR; Alliston KR; Mehzabeen N; Battaile KP; Lovell S; Chang KO; Groutas WC
    J Med Chem; 2015 Apr; 58(7):3144-55. PubMed ID: 25761614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.